ReNeuron Group PLC, a leading researcher in stem cell treatments, has teamed up with Cardiff University and secured a government grant to the amount of two thousand and five hundred pounds (GBP 250,00).
The funding will be used to boost a research program which has already started with the help of the European Cancer Stem Cell Research Institute, which is part of Cardiff University’s science department.
The main goal of the program is to develop systems with which to work out ways to implement therapeutic nucleic acids into cancer treatment plans. The main benefit of these acids is that they have the ability to pass through the blood-brain barrier, which chemotherapy is not able to do.
According to Randolph Corteling, who is the head of the research department at ReNeuron, this program has the potential to find a treatment to diseases, which are harder to diagnose.
Cardiff University boosts scientific research
Advances in medicine are usually a result of extensive scientific research, which is why Cardiff University is looking to expand research programs in the university. Recent advancements in scientific research have made it possible for MRI scans to depict the wiring of individual brains.
The fact that the British government is also looking to invest in such research programs is commendable, as this is the only way to continue the development of medical treatments to severe diseases like cancer.
The funding is also a way for ReNeuron to popularize its activities. Following the announcement for the government grant, the price for an individual share in the company rose by more than half a percent (0.6%).
